Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Stegemann

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Insights Into Imaging|January 13, 2025
Critical reflection on the indication for computed tomography: an interdisciplinary survey of risk and benefit management in patients with sepsisMaria Isabel Opper Hernando, Denis Witham, Ann-Christine Stahl, et al.
Kidney International Reports|April 5, 2021
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19Jan-Hendrik B Hardenberg, Helena Stockmann, Annette Aigner, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Infection|August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
Journal of Clinical Epidemiology|July 13, 2024
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystemAngela M Kunzler, Claire Iannizzi, Jacob Burns, et al.
BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Insights Into Imaging|January 13, 2025
Critical reflection on the indication for computed tomography: an interdisciplinary survey of risk and benefit management in patients with sepsisMaria Isabel Opper Hernando, Denis Witham, Ann-Christine Stahl, et al.
Kidney International Reports|April 5, 2021
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19Jan-Hendrik B Hardenberg, Helena Stockmann, Annette Aigner, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Infection|August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
Journal of Clinical Epidemiology|July 13, 2024
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystemAngela M Kunzler, Claire Iannizzi, Jacob Burns, et al.
BMJ (Clinical Research Ed.)|March 2, 2021
A living WHO guideline on drugs to prevent covid-19François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
BMJ (Clinical Research Ed.)|September 5, 2020
A living WHO guideline on drugs for covid-19Arnav Agarwal, Beverly Hunt, Miriam Stegemann, et al.
Pageof 5